Download here the Workshop Program|
Thursday , June 16th |
||
|
13.00-13.15 |
Welcome address |
|
|
SPEAKER |
TITLE |
|
|
Session 1 |
||
|
13.15-14.00 |
PL1 Ronald T. Raines Massachusetts Institute of Technology Cambridge, USA |
Lessons from Collagen |
|
14.00-14.20 |
O1 Lorenzo Stella University of Roma Tor Vergata Roma, Italy |
Quantification of the association of antimicrobial peptides with live bacterial cells: what have we learned? |
|
14.20-14.40 |
O2 Charles Chen Massachusetts Institute of Technology Cambridge, USA |
In silico-guided design of membrane active peptide-based therapeutics for biomedical applications |
|
14.40-15.00 |
O3 Enrico Federico Semeraro University of Graz Graz, Austria |
Bridging the activity of lactoferricin derivatives in E. coli and lipid-only membranes: partitioning and kinetics |
|
15.00-15.20 |
O4 Myriam Cotten William & Mary |
Piscidins : Anti-infective and Anticancer Copper-binding Peptides at the Crossroads of Neuro-immune Interactions |
|
15.20-15.40 |
O5 Ines Neundorf University of Cologne Cologne, Germany |
Multistep translation of a cell-penetrating peptide into an antimicrobial peptide |
|
15.40-16.00 |
O6 Martin Ulmschneider King’s College London, UK |
Spontaneous assembly of functional membrane proteins from soluble membrane active peptides |
|
16.00-16.20 |
O7 Burkhard Bechinger University of Strasbourg/CNRS Strasbourg, France |
Antimicrobial peptides: Mechanism of action and lipid-mediated synergistic interactions within the membranes |
|
16.20-16.40 |
Coffee Break
|
|
|
Session 2 |
||
|
16.40-17.00 |
O8 Markus Weingarth Utrecht University Utrecht, Netherlands |
The mechanisms of Lipid-targeting Antibiotics |
|
17.00-17.20 |
O9 Chiara Falciani University of Siena Siena, Italy |
Antimicrobial peptides against periodontal bacterial infections |
|
17.20-18.00 |
PL2 Sam Gellman University of Wisconsin Madison, USA |
Impact of Backbone Modifications on Informational Properties of Polypeptides |
|
18.00-18.15 |
O10 Claudia Feurstein Technische Universität Berlin Berlin, Germany |
Structure-activity analysis using computational mining of protein databases to assist design of antimicrobial peptides |
|
18.15-18.35 |
O11 Toni Todorovski Pompeu Fabra University Barcelona, Spain |
Peptide-porphyrin conjugates as promising antivirals against brain-targeting viruses |
|
18.35-18.55 |
O12 Jíři Jiráček Institute of Organic Chemistry and Biochemistry CAS Praha, Czech Republic |
Insulin analogues with altered insulin receptor isoform binding specificities and enhanced aggregation stabilities |
|
18.55-19.15 |
O13 Carla Zannella University of Campania L. Vanvitelli Napoli, Italy |
Host defence amphibian peptides and their potential as antiviral agents |
|
19.15 |
Welcome Party
|
|
|
Friday , June 17th |
||
|
SPEAKER |
TITLE |
|
|
Session 3 |
||
|
8.40-09.20 |
PL3 Kalina Hristova Johns Hopkins University Baltimore, USA |
Peptides for transport across biological barriers |
|
09.20-9.40 |
O14 Rina Aharoni The Weizmann Institute of Science Rehovot, Israel |
The story of the peptide-copolymer Glatiramer Acetate (Copaxone) in the treatment of multiple sclerosis: from Bench to Bed side |
|
9.40-10.00 |
O15 William Wimley Tulane University New Orleans, USA |
Using synthetic molecular evolution to identify host cell compatible antimicrobial peptides effective against drug-resistant and biofilm-forming bacteria, in vitro and in vivo |
|
10.00-10.20 |
O16 Lucia Ferrazzano University of Bologna, Italy |
AMP-based therapy for non-healing wound care: advanced trap&release methods for non-invasive delivery materials |
|
10.20-10.40 |
O17 Alessandro Pini University of Siena Siena, Italy |
A peptide-based medical device for the selective removal of LPS, LTA and living bacteria from the serum of sepsis patients |
|
10.40-11.10 |
Coffee Break & Poster Session
|
|
|
Session 4 |
||
|
11.10-11.30 |
O18 Gil Rosenman Tel Aviv University Tel Aviv, Israel |
Bioinspired Materials: Physical Properties Governed by Biological Refolding |
|
11.30-11.50 |
O19 Maria Moccia National Research Council Bari, Italy |
The Peptide Nucleic Acid leitmotif and its application in miRNAs targeting. |
|
11.50-12.10 |
O20 Francesco Merlino University of Naples Federico II Napoli, Italy |
Pursuit of “Qualified” Antimicrobial Peptides to Challenge the Antibiotic Resistance |
|
12.10-12.30 |
O21 Luigi Aloj University of Cambridge Cambridge, United Kingdom |
Radiolabelled peptides in cancer diagnosis and therapy |
|
12.30-13.50 |
Lunch on site
|
|
|
Session 5 |
||
|
13.50-14.30 |
PL4 Meritxell Teixido IRB Barcelona, Spain |
Blood-Brain Barrier Shuttle Peptides, From Discovery to Applications |
|
14.30-14.50 |
O22 Antonella Accardo University of Naples Federico II Naples, Italy |
Peptide based hydrogels and nanogels for biomedical applications |
|
14.50-15.10 |
O23 Maria Gallo Pompeu Fabra University Barcelona, Spain |
A cognitive protection peptide for cannabis-based pain treatment |
|
15.10-15.30 |
O24 Sharon Gilead Tel Aviv University Tel Aviv, Israel |
Self-Assembled Peptides for Electronic and Piezoelectric Applications |
|
PEPTIDE SHOWCASE |
||
|
15.30-15.45 |
PS1 Antonio Ricci Fresenius Kabi iPSUM Villadose, Italy |
Therapeutic peptide industrial chemistry and analytical consideration |
|
15.45-16.00 |
PS2 Elisabetta Bianchi IRBM Pomezia, Italy |
Development of Analogues of the Venom Toxin ProTx-II as Selective Blockers of the Ion Channel Nav1.7 for the Treatment of Pain |
|
16.00-16.15 |
PS3 Raimund Maier Iris Biotech GmbH Marktredwitz, Germany |
Peptide Optimization by Novel “Fatty” Amino Acids |
|
16.15-16.30 |
PS4 Giorgio Marini CEM Cologno al Serio (BG), Italy |
Optimized Synthesis and Purification Strategies for SPPS |
| 16.30-16.40 |
PS5 Malachi Gillick-Healy KelAda Pharmachem Ltd. Dublin, Irland |
International industrial collaborative opportunities with KelAda Pharmachem Ltd., Ireland |
|
16.40-17.20 |
Coffee Break & Poster Session
|
|
|
Session 6 |
||
|
17.20-18.00 |
PL5 Helma Wennemers ETH Zurich, Zurich, Switzerland |
Synthetic Collagen – From Structure to Function |
|
18.00-18.20 |
O25 Lihi Adler-Abramovich Tel Aviv University Tel Aviv, Israel |
Designing New Bioinspired 3D Hydrogels for Tissue Regeneration |
|
18.20-18.40 |
O26 Evelien Wynendaele Ghent University Ghent, Belgium |
Quorum sensing peptides as microbiota-derived mediators in different diseases |
|
18.40-19.00 |
O27 Norman Metanis The Hebrew University Jerusalem, Israel |
Chemoselective Modification of Cysteine and Selenocysteine in Peptides and Proteins |
|
Free evening |
||
|
Saturday , June 18th |
||
|
SPEAKER |
TITLE |
|
|
Session 7 |
||
|
8.20-9.00 |
PL6 Alessandro Moretto University of Padua Padua, Italy |
From sleepy to lively foldamers: using light to turn-on catalytic activity and programmable protein aggregation |
|
9.00-9.40 |
PL7 Roger Cone University of Michigan Ann Arbor, USA |
Development and application of new MC3R specific melanocortin peptides |
|
9.40-10.00 |
O28 Raquel Lopez-Rios de Castro King's College London, United Kingdom |
Finding an amyloid precursor protein occlusion peptide to reduce the production of toxic Aβ species |
|
10.00-10.20 |
O29 Artur Krezel University of Wroclaw Wroclaw, Poland |
Metal-coupled folding as the driving force for zinc proteins function - insight into sequence-structure-stability relationships in zinc finger, hook and clasp domains |
|
10.20-10.40 |
O30 Carla Isernia University of Campania L. Vanvitelli Caserta, Italy |
Influence of xenobiotic metal ions on structure and folding of the prokaryotic zinc finger Ros87 |
|
10.40-11.10 |
Coffee Break & Poster Session
|
|
|
Session 8 |
||
|
11.10-11.50 |
PL8 Christian Becker University of Vienna Vienna, Austria |
New Tools for Protein Semi-Synthesis to study Posttranslational Modifications |
|
11.50-12.30 |
PL9 Maurizio Pellecchia University of California Riverside, USA |
Targeting protein-protein interactions by designing potent and effective peptide mimetics |
|
12.30-12.50 |
O31 Aphrodite Kapurniotu Technische Universität Munich Freising, Germany |
Designed peptides as potent inhibitors of amyloid self-assembly and cross-seeding of IAPP and Aβ42 |
|
12.50-13.10 |
O32 Nicolas Winssinger University of Geneva Switzerland |
PNA to encode and fold peptide |
|
13.10-14.10 |
Free Lunch
|
|
|
Session 9 |
||
|
14.10-14.30 |
O33 Luca Gentilucci University of Bologna Bologna, Italy |
Hybrid α/β Peptide Ligands Targeting α4β1 Integrin: Therapeutic and Diagnostic Applications |
|
14.30-14.50 |
O34 Pol Besenius Johannes Gutenberg University Mainz Mainz, Germany |
Multicomponent Supramolecular Polymers as a Platform for the Design of Glycoconjugate Vaccines |
|
14.50-15.10 |
O35 Alessandro Gori SCITEC-CNR Milano, Italy |
Membrane-binding Peptides for Extracellular Vesicles On-chip Analysis |
|
Session 10 |
||
|
15.10-15.50 |
PL10 Christian Heinis Ecole Polytechinque Federale de Lausanne Lausanne, Switzerland |
New methods and attempts to develop orally available cyclic peptides |
|
15.50-16.10 |
O36 Marina Rubini University College Dublin Dublin, Ireland |
Semisynthetic approaches for studying post-translational modifications |
|
16.10-16.30 |
O37 Claudia Tomasini Università di Bologna Bologna, Italy |
Physical gels formed by Dopa-containing ultra-short peptides |
|
16.30-16.50 |
O38 Giancarlo Terraneo Politecnico di Milano Milano, Italy |
Halogenation as versatile tool for tuning structures and properties of amyloid peptides |
|
16.50-17.10 |
O39 Giulia Marafon ETH Zurich Switzerland |
Design of enzyme-inspired multivalent catalysts through functional patterning of nanosystems |
|
17.10-17.30 |
O40 Manuela Grimaldi University of Salerno, Salerno, Italy |
Tissue engineering and differentiation on neuronal stem cell targets through membrane active peptide |
|
17.30-18.00 |
Coffee Break & Poster Session
|
|
|
18.00-18.20 |
O41 Marta De Zotti University of Padua Padua, Italy |
A linear antimicrobial peptide selectively detects sulfate anions |
|
18.20-18.40 |
O42 Alice Romagnoli Università Politecnica delle Marche Ancona, Italy |
Lost in translation: development of single and novel therapeutic peptidomimetic against multiple pathologies |
|
18.40-19.00 |
O43 Elad Arad Ben-Gurion University of the Negev Beersheba, Israel |
beta-amyloid fibrils catalyze neurotransmitter degradation |
|
19.00-19.10 |
Concluding Remarks
|
|
|
21.00 |
Gala Dinner |
|